XML 22 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Impact of Adopting CECL (ASU 2016-13)
Common Stock
Retained Earnings
Retained Earnings
Impact of Adopting CECL (ASU 2016-13)
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Sep. 30, 2022     8,221,952      
Beginning Balance at Sep. 30, 2022 $ 218,569   $ 38,751 $ 180,535   $ (717)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 27,118     27,118    
Other comprehensive (loss) income (367)         (367)
Repurchase of common stock (in shares)     (185,399)      
Repurchase of common stock, net of tax $ (4,998)   $ (4,998)      
Restricted stock grants (in shares) 26,150          
Exercise of stock options (in shares) 42,635   42,635      
Exercise of stock options $ 698   $ 698      
Common stock dividends (8,267)     (8,267)    
Stock-based compensation expense 320          
Ending Balance at Sep. 30, 2023 233,073 $ (488) $ 34,771 199,386   (1,084)
Ending Balance (in shares) at Sep. 30, 2023     8,105,338      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 24,283     24,283    
Other comprehensive (loss) income 1,104         1,104
Repurchase of common stock (in shares)     (218,976)      
Repurchase of common stock, net of tax $ (5,958)   $ (5,958)      
Restricted stock grants (in shares) 28,615          
Exercise of stock options (in shares) 45,150   45,150      
Exercise of stock options $ 659   $ 659      
Common stock dividends (7,650)     (7,650)    
Stock-based compensation expense 390   390      
Ending Balance at Sep. 30, 2024 245,413 $ (488) $ 29,862 215,531 $ (488) 20
Ending Balance (in shares) at Sep. 30, 2024     7,960,127      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 29,161     29,161    
Other comprehensive (loss) income (318)         (318)
Repurchase of common stock (in shares)     (179,966)      
Repurchase of common stock, net of tax $ (5,759)   $ (5,759)      
Restricted stock grants (in shares) 33,200          
Exercise of stock options (in shares) 76,210   76,210      
Exercise of stock options $ 1,665   $ 1,665      
Common stock dividends (8,085)     (8,085)    
Stock-based compensation expense 537   537      
Ending Balance at Sep. 30, 2025 $ 262,614   $ 26,305 $ 236,607   $ (298)
Ending Balance (in shares) at Sep. 30, 2025     7,889,571